Dasgupta et al. noted that PFKFB4 can phosphorylate the steroid receptor coactivator-3 (SRC-3) and lead to enhance ER co-activation and cell proliferation in human breast cancer [56]. This evidence concerns the gene PFKFB4 and breast carcinoma.